Conditions: Schizophrenia
Keywords: Schizophrenia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 244
Healthy volunteers: no

Brief summary:
This will be a multicenter, 52 week, open label study to assess the safety and tolerability of oral OPC-34712 (1 to 6 mg) as monotherapy in adult patients with schizophrenia. The study will be conducted on an outpatient basis. Enrollment into the study will be drawn from eligible subjects who have completed participation in Study 331-07- 203 and who, in the investigator's judgment, would benefit from continued treatment with oral OPC-34712.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: OPC-34712
Intervention descriptions: intervention 1: oral administered once daily

Protocol document: